116 related articles for article (PubMed ID: 8944771)
1. Expression and characterization of human perlecan domains I and II synthesized by baculovirus-infected insect cells.
Groffen AJ; Buskens CA; Tryggvason K; Veerkamp JH; Monnens LA; van den Heuvel LP
Eur J Biochem; 1996 Nov; 241(3):827-34. PubMed ID: 8944771
[TBL] [Abstract][Full Text] [Related]
2. Formation of heparan sulfate or chondroitin/dermatan sulfate on recombinant domain I of mouse perlecan expressed in Chinese hamster ovary cells.
Kokenyesi R; Silbert JE
Biochem Biophys Res Commun; 1995 Jun; 211(1):262-7. PubMed ID: 7779094
[TBL] [Abstract][Full Text] [Related]
3. Expression of the basement membrane heparan sulfate proteoglycan (perlecan) in human synovium and in cultured human synovial cells.
Dodge GR; Boesler EW; Jimenez SA
Lab Invest; 1995 Nov; 73(5):649-57. PubMed ID: 7474938
[TBL] [Abstract][Full Text] [Related]
4. Proteoglycan production by human glomerular visceral epithelial cells and mesangial cells in vitro.
van Det NF; van den Born J; Tamsma JT; Verhagen NA; van den Heuvel LP; Berden JH; Bruijn JA; Daha MR; van der Woude FJ
Biochem J; 1995 May; 307 ( Pt 3)(Pt 3):759-68. PubMed ID: 7537959
[TBL] [Abstract][Full Text] [Related]
5. Widespread expression of perlecan proteoglycan in basement membranes and extracellular matrices of human tissues as detected by a novel monoclonal antibody against domain III and by in situ hybridization.
Murdoch AD; Liu B; Schwarting R; Tuan RS; Iozzo RV
J Histochem Cytochem; 1994 Feb; 42(2):239-49. PubMed ID: 7507142
[TBL] [Abstract][Full Text] [Related]
6. Characterization of proteoglycans synthesized by murine embryonal carcinoma cells (P19) reveals increased expression of perlecan (heparan sulfate proteoglycan) during neuronal differentiation.
Sekiguchi RT; Potter-Perigo S; Braun K; Miller J; Ngo C; Fukuchi K; Wight TN; Kimata K; Snow AD
J Neurosci Res; 1994 Aug; 38(6):670-86. PubMed ID: 7807583
[TBL] [Abstract][Full Text] [Related]
7. The C-terminal domain V of perlecan promotes beta1 integrin-mediated cell adhesion, binds heparin, nidogen and fibulin-2 and can be modified by glycosaminoglycans.
Brown JC; Sasaki T; Göhring W; Yamada Y; Timpl R
Eur J Biochem; 1997 Nov; 250(1):39-46. PubMed ID: 9431988
[TBL] [Abstract][Full Text] [Related]
8. Differential binding of vascular cell-derived proteoglycans (perlecan, biglycan, decorin, and versican) to the beta-amyloid protein of Alzheimer's disease.
Snow AD; Kinsella MG; Parks E; Sekiguchi RT; Miller JD; Kimata K; Wight TN
Arch Biochem Biophys; 1995 Jun; 320(1):84-95. PubMed ID: 7793988
[TBL] [Abstract][Full Text] [Related]
9. Proteoglycans in polarized epithelial Madin-Darby canine kidney cells.
Svennevig K; Prydz K; Kolset SO
Biochem J; 1995 Nov; 311 ( Pt 3)(Pt 3):881-8. PubMed ID: 7487945
[TBL] [Abstract][Full Text] [Related]
10. Structural properties of recombinant domain III-3 of perlecan containing a globular domain inserted into an epidermal-growth-factor-like motif.
Schulze B; Mann K; Battistutta R; Wiedemann H; Timpl R
Eur J Biochem; 1995 Aug; 231(3):551-6. PubMed ID: 7649154
[TBL] [Abstract][Full Text] [Related]
11. Expression of human perlecan domain I as a recombinant heparan sulfate proteoglycan with 20-kDa glycosaminoglycan chains.
Graham LD; Whitelock JM; Underwood PA
Biochem Biophys Res Commun; 1999 Mar; 256(3):542-8. PubMed ID: 10080934
[TBL] [Abstract][Full Text] [Related]
12. Cyclic AMP regulates basement membrane heparan sulfate proteoglycan, perlecan, metabolism in rat glomerular epithelial cells.
Ko CW; Bhandari B; Yee J; Terhune WC; Maldonado R; Kasinath BS
Mol Cell Biochem; 1996 Sep; 162(1):65-73. PubMed ID: 8905627
[TBL] [Abstract][Full Text] [Related]
13. Evidence for the existence of multiple heparan sulfate proteoglycans in the human glomerular basement membrane and mesangial matrix.
Groffen AJ; Hop FW; Tryggvason K; Dijkman H; Assmann KJ; Veerkamp JH; Monnens LA; Van den Heuvel LP
Eur J Biochem; 1997 Jul; 247(1):175-82. PubMed ID: 9249024
[TBL] [Abstract][Full Text] [Related]
14. The proteoglycan perlecan is expressed in the erythroleukemia cell line K562 and is upregulated by sodium butyrate and phorbol ester.
Grässel S; Cohen IR; Murdoch AD; Eichstetter I; Iozzo RV
Mol Cell Biochem; 1995 Apr; 145(1):61-8. PubMed ID: 7544867
[TBL] [Abstract][Full Text] [Related]
15. Antibody mapping and tissue localization of globular and cysteine-rich regions of perlecan domain III.
Couchman JR; Ljubimov AV; Sthanam M; Horchar T; Hassell JR
J Histochem Cytochem; 1995 Sep; 43(9):955-63. PubMed ID: 7543915
[TBL] [Abstract][Full Text] [Related]
16. Perlecan domain V of Drosophila melanogaster. Sequence, recombinant analysis and tissue expression.
Friedrich MV; Schneider M; Timpl R; Baumgartner S
Eur J Biochem; 2000 Jun; 267(11):3149-59. PubMed ID: 10824099
[TBL] [Abstract][Full Text] [Related]
17. Non-glycosaminoglycan bearing domains of perlecan and aggrecan influence the utilization of sites for heparan and chondroitin sulfate synthesis.
Doege K; Chen X; Cornuet PK; Hassell J
Matrix Biol; 1997 Oct; 16(4):211-21. PubMed ID: 9402011
[TBL] [Abstract][Full Text] [Related]
18. Antisense targeting of perlecan blocks tumor growth and angiogenesis in vivo.
Sharma B; Handler M; Eichstetter I; Whitelock JM; Nugent MA; Iozzo RV
J Clin Invest; 1998 Oct; 102(8):1599-608. PubMed ID: 9788974
[TBL] [Abstract][Full Text] [Related]
19. Suppression of autocrine and paracrine functions of basic fibroblast growth factor by stable expression of perlecan antisense cDNA.
Aviezer D; Iozzo RV; Noonan DM; Yayon A
Mol Cell Biol; 1997 Apr; 17(4):1938-46. PubMed ID: 9121441
[TBL] [Abstract][Full Text] [Related]
20. Heparan and chondroitin sulfate on growth plate perlecan mediate binding and delivery of FGF-2 to FGF receptors.
Smith SM; West LA; Govindraj P; Zhang X; Ornitz DM; Hassell JR
Matrix Biol; 2007 Apr; 26(3):175-84. PubMed ID: 17169545
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
